GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $208,200 | -89.0% | 250,000 | -83.4% | 0.03% | -86.1% |
Q1 2023 | $1,893,611 | -50.7% | 1,502,866 | -15.2% | 0.24% | -58.6% |
Q4 2022 | $3,844,253 | -16.9% | 1,771,545 | +358.5% | 0.59% | -39.5% |
Q3 2022 | $4,628,000 | -76.5% | 386,349 | -83.6% | 0.98% | -80.6% |
Q2 2022 | $19,673,000 | +23.7% | 2,350,448 | +28.3% | 5.02% | -2.6% |
Q1 2022 | $15,908,000 | +38.3% | 1,832,704 | +80.2% | 5.16% | -16.1% |
Q4 2021 | $11,501,000 | – | 1,016,857 | – | 6.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |